A. Atkins

HIV-1 cure strategies: why CRISPR?

E. Haddad, M. Nonnemacher, B. Wigdahl, 2020, Expert opinion on biological therapy.

Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency.

M. Nonnemacher, B. Wigdahl, C. Chung, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites

M. Nonnemacher, B. Wigdahl, C. Chung, 2020, Molecular therapy. Nucleic acids.

Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients

J. Mell, M. Nonnemacher, G. Ehrlich, 2019, Scientific Reports.

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection

K. Khalili, M. Nonnemacher, B. Wigdahl, 2018, Front. Microbiol..

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy

M. Nonnemacher, I. Sariyer, B. Wigdahl, 2021, Frontiers in Genome Editing.

CRSeek: a Python module for facilitating complicated CRISPR design strategies

Will Dampier, Cheng-Han Chung, Neil T. Sullivan, 2018 .

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing

Will Dampier, Cheng-Han Chung, Neil T. Sullivan, 2020, Frontiers in Microbiology.

Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy

M. Nonnemacher, B. Wigdahl, C. Chung, 2021, Frontiers in Cellular and Infection Microbiology.